Response to Letter to the Editor: "Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin"
J Endocr Soc
.
2020 Feb 29;4(3):bvaa006.
doi: 10.1210/jendso/bvaa006.
eCollection 2020 Mar 1.
Authors
Jessica R Wilson
1
2
3
,
Megan M Shuey
1
,
Nancy J Brown
1
,
Jessica K Devin
2
4
Affiliations
1
Division of Clinical Pharmacology, Vanderbilt Department of Medicine, Nashville, Tennessee.
2
Division of Endocrinology, Diabetes, and Metabolism, Vanderbilt Department of Medicine, Nashville, Tennessee.
3
Division of Endocrinology, Diabetes and Metabolism, University of Pennsylvania Department of Medicine, Philadelphia, Pennsylvania.
4
UCHealth Endocrinology, Yampa Valley Medical Center, Steamboat Springs, Colorado.
PMID:
32133430
PMCID:
PMC7049288
DOI:
10.1210/jendso/bvaa006
No abstract available
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States